What is Customer Demographics and Target Market of Avanos Company?

Avanos Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who are Avanos Medical's customers?

Avanos Medical, Inc. transformed from its origins as Halyard Health, Inc. after spinning off from Kimberly-Clark in 2014. This strategic separation allowed the company to hone its focus within the medical technology sector.

The company has strategically divested certain business segments, notably its Surgical & Infection Prevention division in 2017 and its Respiratory Health business in 2023. These moves underscore a deliberate shift towards higher-growth, specialized areas.

What is Customer Demographics and Target Market of Avanos Medical?

Avanos Medical's target market primarily consists of healthcare professionals and institutions. This includes hospitals, surgical centers, and clinics that utilize their specialized medical devices. The company's focus on pain management and recovery, as well as digestive health, means their customer base is concentrated among physicians, nurses, and procurement departments within these healthcare settings. Understanding the needs of these medical professionals is crucial for the effective distribution and application of products like their Avanos PESTEL Analysis, which aids in managing patient recovery and digestive health.

Avanos Medical primarily serves healthcare providers, operating within a Business-to-Business model. Its core customer segments are hospitals, ambulatory surgery centers, and long-term care facilities. The company focuses on two main product areas: Pain Management & Recovery and Specialty Nutrition Systems.

Pain Management & Recovery Customers

This segment targets anesthesiologists, interventional pain specialists, and C-suite executives. It also includes sports medicine and rheumatology professionals. This area accounted for 33.69% of total revenue in 2024.

Specialty Nutrition Systems Customers

Key customers here are critical care physicians and nurses, neonatologists, NICU nurses, and dietitians. This segment generated 60.61% of total revenue in 2024, with Q1 2025 sales reaching $101.1 million.

Avanos has strategically refined its focus, divesting non-core businesses to concentrate on higher-growth medical devices. This shift, part of a transformation initiated in January 2023, aims to enhance its position in pain management and nutrition markets. Understanding Avanos target market for pain management solutions is key to appreciating their strategic direction.

Strategic Market Focus

Avanos Medical's customer segmentation strategy reflects a deliberate move towards specialized healthcare solutions. The company's market positioning and demographics are shaped by its commitment to clinically differentiated products.

• Hospitals
• Ambulatory Surgery Centers
• Long-Term Care Facilities
• Specialty Clinics

Avanos SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Avanos Medical's customer base, primarily healthcare providers, prioritizes solutions that demonstrably improve patient outcomes and streamline clinical workflows. Their needs are deeply rooted in clinical efficacy, ease of use, and a strong emphasis on patient safety and recovery.

Clinical Superiority and Innovation

Healthcare providers seek innovative medical solutions that lead to faster patient recovery and minimize complications. A significant driver is the reduction of opioid usage, a critical public health concern.

Operational Efficiency

Products that save time for clinical staff, such as the CORPAK 2 system designed for nurses and physicians, are highly valued. This focus on efficiency directly impacts the ability to manage patient care effectively.

Cost-Effectiveness and Proven Efficacy

Decision-making is heavily influenced by proven efficacy, reliability, and long-term cost savings. Healthcare facilities evaluate clinical evidence and regulatory compliance to ensure value and patient safety.

Addressing Key Pain Points

Common challenges addressed include managing short-term enteral feeding for critical patients and providing effective non-opioid pain relief post-surgery. These are areas where providers actively seek advanced solutions.

Reimbursement and Regulatory Influence

Regulatory changes, like the NOPAIN Act effective January 1, 2025, which provides separate reimbursement for certain infusion pumps, directly influence purchasing decisions and the adoption of specific technologies.

Customer-Driven Development

Customer feedback and market trends are integral to product development. Continuous investment in R&D aims to enhance existing products and introduce new solutions that meet evolving clinical needs.

Tailored Solutions for Diverse Needs

The company offers a broad spectrum of products designed to cater to various patient demographics, from neonates to geriatric patients, and a growing range of non-opioid pain management options. This segmentation strategy ensures personalized solutions for distinct clinical requirements.

• Focus on improving patient outcomes.
• Emphasis on operational efficiency for healthcare staff.
• Preference for clinically proven and reliable products.
• Demand for solutions that reduce opioid reliance.
• Interest in products that offer long-term cost savings.
• Value placed on ease of use and patient safety.

Understanding the Growth Strategy of Avanos reveals how these customer needs inform their market approach and product innovation.

Avanos PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Avanos Medical operates globally, serving over 90 countries with its medical devices and solutions. Its core markets include North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America, where it holds significant positions across various product categories.

Global Reach and Key Markets

Avanos Medical's operations span more than 90 countries, with a strong presence in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company has established robust market positions within these diverse geographical regions.

Distribution Strategies

In 2024, approximately 50% of North American sales were through distributors like McKesson and Medline. Outside North America, 67% of net sales utilized wholesalers or distributors, indicating varied market entry approaches.

Logistics and Infrastructure

To support its extensive international operations, Avanos strategically places distribution centers in North America, Europe, Australia, and Japan. This network ensures efficient delivery of its products to healthcare providers worldwide.

Market Adaptation and Strategic Focus

Avanos adapts its strategies to local regulatory environments, such as EU MDR compliance, and healthcare system demands. Recent strategic moves include expanding direct operations for MIC-KEY Enteral Feeding Products in the UK from July 2025 and portfolio optimization through acquisitions and divestitures.

The company's approach to understanding Avanos target market for pain management solutions involves recognizing demographic differences and buying power variations across its global presence. This is evident in its strategic focus on markets where it holds a strong position, as demonstrated by its Marketing Strategy of Avanos, which includes targeted acquisitions and divestitures to refine its product and geographic portfolio.

Avanos Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Avanos Medical employs a robust strategy for acquiring and retaining its business-to-business healthcare clientele, utilizing a blend of direct sales, distribution channels, and strategic alliances. The company's primary engagement with hospitals and ambulatory care centers globally is facilitated by a dedicated sales force and third-party wholesale distributors.

Direct Sales and Distribution Networks

Avanos Medical relies on a direct sales force and third-party distributors to reach healthcare providers. In 2024, distributors accounted for approximately 50% of North American net sales and 67% of sales outside North America, underscoring their critical role.

Marketing and Sales Tactics

Marketing efforts include professional education, clinical evidence sharing, and digital engagement. Sales strategies focus on solution selling, highlighting clinical advantages and economic benefits for providers.

Customer Support and Education

The company provides comprehensive customer support, product training, and educational programs to ensure effective product use and build strong client relationships.

Data-Driven Approach and Strategic Evolution

Customer data and CRM systems are utilized for targeted campaigns, indicating a data-driven approach to understanding customer needs. The company's ongoing adaptation and innovation reflect a commitment to meeting evolving patient and provider demands.

Avanos Medical's customer acquisition and retention strategies are significantly influenced by legislative changes and market demand. The Non-Opioid Policy for Pain Relief (NOPAIN) Act, effective January 1, 2025, is expected to boost the value proposition of its ON-Q and ambIT infusion pumps by expanding Medicare reimbursement for non-opioid solutions. Additionally, strong demand for ENFit conversions in North America has positively impacted the Digestive Health segment. The company's three-year transformation, initiated in January 2023, focuses on portfolio optimization and cost management to target high-potential markets and improve customer lifetime value. This strategic focus is supported by the company's financial performance, including a free cash flow generation of $82.9 million in 2024, which enables continued investment in these customer-centric initiatives. Understanding the Mission, Vision & Core Values of Avanos provides further context to their strategic direction.

Impact of NOPAIN Act

The NOPAIN Act, effective January 1, 2025, enhances reimbursement for non-opioid pain relief solutions like ON-Q and ambIT infusion pumps, improving their market appeal.

ENFit Conversions

Strong demand for ENFit conversions in North America has provided a positive boost to the Digestive Health segment of the business.

Transformation Initiative

A three-year transformation process, started in January 2023, involves portfolio rationalization and cost management to concentrate on high-growth markets and increase customer lifetime value.

Financial Support for Strategy

The company's ability to generate significant free cash flow, amounting to $82.9 million in 2024, supports strategic investments in customer acquisition and retention.

Solution Selling Approach

Sales tactics emphasize solution selling, focusing on the clinical superiority and economic advantages of products for healthcare providers.

Customer Engagement Channels

Engagement extends through professional education, clinical evidence dissemination, and digital platforms, reinforcing customer relationships.

Avanos Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔